Unitree, one of China’s leading humanoid robot makers, is looking to raise $610 million through an IPO on the Shanghai stock exchange, according to The Information.
That’s a massive capital raise for a robotics company, and it signals just how seriously investors are taking the humanoid robot space right now.
Why This Matters
Unitree has built its reputation on affordable, agile quadruped robots (think: robot dogs that do backflips). More recently, the company has pushed hard into humanoid robotics with its G1 and H1 models, positioning itself as a direct competitor to firms like Figure AI, Tesla’s Optimus program, and Agility Robotics.
A $610 million raise would give Unitree serious firepower to scale manufacturing and accelerate R&D at a critical moment. The humanoid robotics market is in an arms race, with multiple well-funded players racing to deliver commercially viable robots for warehouses, factories, and eventually homes.
The Bigger Picture
This IPO attempt comes during a wave of robotics investment globally:
- Figure AI raised $675 million at a $2.6 billion valuation in early 2024, then continued raising
- Tesla keeps pushing its Optimus humanoid timeline forward
- Chinese competitors like Fourier Intelligence, UBTECH, and now Unitree are scaling fast with government support and manufacturing cost advantages
China’s robotics sector has particular tailwinds. The Chinese government has explicitly named humanoid robots as a strategic priority, with policy targets calling for mass production capabilities by 2025-2027. Unitree choosing a Shanghai listing (rather than Hong Kong or the US) keeps it aligned with domestic policy support and avoids geopolitical friction around US listings for Chinese AI/robotics firms.
What Stands Out
Unitree’s pitch is different from most humanoid competitors. The company has consistently prioritized cost efficiency. Its G1 humanoid launched with a starting price under $16,000, dramatically undercutting Western competitors whose prototypes cost hundreds of thousands. If Unitree can maintain that pricing advantage at scale, it could define the affordable end of the humanoid market.
The $610 million target also reflects how much capital humanoid development actually requires. Building robots that can reliably navigate real-world environments, handle objects with dexterity, and operate safely around humans is an engineering challenge that burns through cash fast. This raise would fund the transition from impressive demos to actual deployed products.
What to Watch
The IPO pricing and investor demand will be a real-time gauge of market confidence in humanoid robotics as a near-term commercial reality, not just a long-term vision. If Unitree prices successfully, expect it to accelerate the funding race across the entire sector.
More details are available in the original report from The Information.